Description:

NSABP-B-47 Cardiac Report Follow-Up Form (Form CR-F) A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women With Node- Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=95D01C7E-6A9D-38AE-E040-BB89AD4351B3

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=95D01C7E-6A9D-38AE-E040-BB89AD4351B3
Keywords:
  1. 8/27/12 8/27/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
Uploaded on:

January 9, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT01275677 Follow-Up - NSABP-B-47 Cardiac Report Follow-Up Form (Form CR-F) - 3162754v1.0

This paper worksheet may be completed to facilitate the entry of the information in NSABP Coordinator Online. Partially completed worksheets may be saved in Coordinator Online. DO NOT SUBMIT THIS WORKSHEET VIA FAX OR MAIL. Following receipt of a Cardiac Report form (Form CR), the documentation will be reviewed to determine if routine submission of a Cardiac Report Follow-up form (Form CR-F) will be required. The decision will be conveyed to the institution's Program Coordinator. If cardiac follow-up is required, Form CR-F must be submitted for 2 years, approximately every 6 months following the date of confirmatory LVEF reported on Form CR. (Submission of Form CR-F should be timed to coincide with submission of the B-47 Follow-up form (Form F).)

Header
Reporting Period
Reporting Period
Cardiac Information
Has the patient had symptoms of CHF since the previous report (Previous report will be Form CR if this is the first CR-F form submitted.)
How would you classify the symptoms of congestive heart failure (If yes)
Has the patient had one or more LVEF assessments since the previous report (Form LVA should be submitted any time through 10 years following randomization when a non-protocol specified LVEF assessment has been performed because the patient has signs or symptoms of CHF see Protocol Section 5.3. Please submit all LVEF assessments since the previous report)
Has the patient received medications for heart failure and/or hypertension since the previous report
Medications (Mark all that apply)
Medication Reason (Mark all reasons that apply)
Footer

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial